Detalhe da pesquisa
1.
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
BJU Int
; 133(2): 214-222, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803523
2.
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer.
Eur Urol Oncol
; 7(3): 614-624, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184473
3.
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
Mol Diagn Ther
; 27(1): 5-13, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401787
4.
Different Response to Immunotherapy According to Melanoma Histologic Subtype.
J Immunother
; 45(2): 119-124, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34908006
5.
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 5(8): e2226252, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972744
6.
Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials.
Eur Urol
; 85(3): 303, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087732
7.
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Front Oncol
; 9: 622, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355139
8.
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis.
Eur Urol
; 84(6): 602-603, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451897